Aristeia Capital »

Ani Pharmaceuticals shares owned by Aristeia Capital

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Aristeia Capital from 13F filings

Historical chart of Aristeia Capital investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Aristeia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Aristeia Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.9M 8.0M 1.24

More positions owned by Aristeia Capital

Wix.com SHS (WIX)
SM Energy (SM)
Strategy Note 12/0 (Principal)
Iac Com New (IAC)
SPDR S&P 500 ETF Trust Tr Unit Put Option (SPY)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Evergy Note 4.500%12/1 (Principal)
Guardant Health Note 11/1 (Principal)
HEICO Corporation Cl A (HEI.A)
Super Micro Computer Note 3.500% 3/0 (Principal)
Alibaba Group Holding Note 0.500% 6/0 (Principal)
Strategy Note 3/0 (Principal)
Super Micro Computer Note 2.250% 7/1 (Principal)
Liberty Broadband Corporation Com Ser C (LBRDK)
Atlanta Braves Holdings Com Ser C (BATRK)

View all positions for Aristeia Capital

Top funds holding Ani Pharmaceuticals

Camden Asset Management
Alberta Investment Management Corporation
Citadel Advisors
Empyrean Capital Partners
HBK Investments
Point72 Asset Management
Balyasny Asset Management
Readystate Asset Management
BlackRock
Absolute Investment Advisers
Universal- Beteiligungs- und Servicegesellschaft mbH
Aristeia Capital
Leucadia National Corporation
Gabelli Funds
Susquehanna Advisors Group

View all funds holding Ani Pharmaceuticals